Korean companies urged to seek M&As to counter drug price cuts and US FTA

Published: 2011-12-15 06:58:00
Updated: 2011-12-15 06:58:00
Domestic drug makers should focus on seeking mergers & acquisitions (M&As) to enlarge their sales volume to survive in an era of the Korea-U.S. FTA and massive drug price cuts, an expert said.

“Local companies should seek a feasible method to maximize the synergistic effects through M&A among ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.